BlackRock
AGN

BlackRock’s Allergan plc AGN Stock Holding History

BlackRock’s Portfolio AGN Stock Details AGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-21,136,493
Closed -$3.74B – 5225
2020
Q1 		$3.74B Buy
21,136,493
+328,700
+2% +$61.9M 0.18% 104
2019
Q4 		$3.98B Buy
20,807,793
+257,692
+1% +$46.5M 0.15% 121
2019
Q3 		$3.46B Buy
20,550,101
+748,168
+4% +$122M 0.15% 133
2019
Q2 		$3.32B Sell
19,801,933
-1,035,138
-5% -$143M 0.14% 133
2019
Q1 		$3.05B Sell
20,837,071
-628,946
-3% -$91.2M 0.14% 139
2018
Q4 		$2.87B Buy
21,466,017
+637,735
+3% +$105M 0.14% 126
2018
Q3 		$3.97B Sell
20,828,282
-653,520
-3% -$120M 0.17% 106
2018
Q2 		$3.58B Buy
21,481,802
+929,836
+5% +$149M 0.17% 110
2018
Q1 		$3.46B Buy
20,551,966
+229,361
+1% +$38.5M 0.17% 110
2017
Q4 		$3.32B Buy
20,322,605
+362,003
+2% +$65M 0.16% 122
2017
Q3 		$4.09B Buy
19,960,602
+35,823
+0.2% +$8.33M 0.21% 88
2017
Q2 		$4.84B Sell
19,924,779
-701,400
-3% -$165M 0.26% 71
2017
Q1 		$4.93B Buy
20,626,179
+19,806,359
+2,416% +$4.61B 0.27% 66
2016
Q4 		$172M Sell
819,820
-16,472
-2% -$3.41M 0.24% 75
2016
Q3 		$193M Sell
836,292
-76,052
-8% -$18.6M 0.28% 70
2016
Q2 		$211M Buy
912,344
+7,482
+0.8% +$1.73M 0.32% 62
2016
Q1 		$243M Sell
904,862
-197,747
-18% -$56.6M 0.39% 51
2015
Q4 		$345M Sell
1,102,609
-34,567
-3% -$10.3M 0.51% 41
2015
Q3 		$309M Buy
1,137,176
+83,833
+8% +$25.8M 0.48% 43
2015
Q2 		$320M Sell
1,053,343
-112,116
-10% -$33.4M 0.47% 45
2015
Q1 		$347M Buy
1,165,459
+354,037
+44% +$101M 0.48% 48
2014
Q4 		$209M Sell
811,422
-488,907
-38% -$122M 0.3% 70
2014
Q3 		$314M Buy
1,300,329
+490,359
+61% +$110M 0.46% 47
2014
Q2 		$181M Buy
809,970
+273,172
+51% +$56.6M 0.27% 83
2014
Q1 		$111M Sell
536,798
-86,985
-14% -$17.2M 0.18% 126
2013
Q4 		$105M Buy
623,783
+327,032
+110% +$51.1M 0.17% 132
2013
Q3 		$42.7M Buy
296,751
+37,112
+14% +$4.94M 0.08% 261
2013
Q2 		$32.8M Buy
+259,639
New +$29.4M 0.07% 305

Other funds holding AGN

AJ
Ashburton (Jersey) St Helier, Jersey $227M AUM
C
Cerebellum San Francisco, California $21.5M AUM
B
Barings Charlotte, North Carolina $6.19B AUM 16.5% 1-Year Est. Return
JJ
JDC-JSC New York $20.8M AUM 30.94% 1-Year Est. Return
VFA
Valeo Financial Advisors Carmel, Indiana $4.74B AUM 27.69% 1-Year Est. Return
OPS
Orion Portfolio Solutions Omaha, Nebraska $10.2B AUM 6.73% 1-Year Est. Return

BlackRock's AGN Position: Q2 2020 in Review

BlackRock sold out of Allergan plc (AGN) in Q2 2020, closing a stake of 21,136,493 shares — an estimated $3.74B sold.

BlackRock first reported a position in AGN in Q2 2013 and held it in 28 quarters. The position peaked at $4.93B in Q1 2017. 7 funds tracked by Wall St. Rank hold AGN as of Q2 2020.

  • BlackRock reported no remaining Allergan plc position as of Q2 2020 after selling out during the quarter.
  • BlackRock sold 21,136,493 Allergan plc shares in Q2 2020, an estimated $3.74B.
  • BlackRock first reported a position in Allergan plc in Q2 2013 and held it in 28 quarters.
  • BlackRock's Allergan plc position peaked at $4.93B in Q1 2017.
  • 7 funds tracked by Wall St. Rank held Allergan plc as of Q2 2020.

Based on BlackRock's 13F filing for Q2 2020, filed 14 Aug 2020.